Homoserine Lactone

Homoserine Lactone

SCHEMBL787339

Cl.N[C@H]1CCOC1=O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Homoserine Lactone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118108634-A Synthesis method of glufosinate-ammonium intermediate chlorohomoserine ester 南京盛德创赢生物科技有限公司 2024-05-31 CN claimed
CN-117964654-A Synthesis method of arginate-ammonium phosphonate 南京盛德创赢生物科技有限公司 2024-05-03 CN claimed
CN-117603166-A Preparation method of synthetic intermediate (S) - (2-oxo-tetrahydrofuran-3-yl) carbamate of glufosinate-ammonium 湖北泰盛化工有限公司 2024-02-27 CN claimed
CN-117603258-A Synthesis method of L-glufosinate-ammonium and salt thereof 江苏七洲绿色化工股份有限公司 2024-02-27 CN claimed
CN-117585803-A Denitrifying carbon source and preparation method and application thereof 南京乐透思高新材料科技有限公司 2024-02-23 CN claimed
CN-117186036-A Preparation method of acetyl-L-homoserine lactone 湖北泰盛化工有限公司 2023-12-08 CN claimed
CN-116171270-A Preparation method of (S) -4-chloro-2-aminobutyric acid hydrochloride and (S) -4-chloro-2-aminobutyric acid ester 利尔化学股份有限公司 2023-05-26 CN claimed
CN-110372642-B Method for treating homoserine-based compounds CJ第一制糖株式会社 2023-04-07 CN claimed
WO-2023051768-A1 METHODS FOR PREPARING (S)-4-CHLORO-2-AMINOBUTYRIC ACID HYDROCHLORIDE AND (S)-4-CHLORO-2-AMINOBUTYRATE 利尔化学股份有限公司 2023-04-06 WO claimed
CN-110003148-B Preparation method of homoserine lactone hydrochloride 安徽安力肽生物科技有限公司 2023-03-24 CN claimed
CN-110003148-A A kind of preparation method of homoserine lactone hydrochloride 安徽安力肽生物科技有限公司 2019-07-12 CN claimed
CN-107098874-B N- Thioacyl homoserine lactone class compound, preparation method and the application replaced containing phenylurea 郑州大学 2019-04-30 CN claimed
CN-106458948-B Method for treating homoserine-based compounds CJ第制糖株式会社 2019-02-15 CN claimed
US-10100026-B2 Process for treating homoserine-based compound CJ CHEILJEDANG CORPORATION (KR) 2018-10-16 US claimed
CN-107098874-A N Thioacyl homoserine lactone classes compound, its preparation method and the application replaced containing phenylurea 郑州大学 2017-08-29 CN claimed
CN-106458948-A Method for treating homoserine-based compounds CJ第制糖株式会社 2017-02-22 CN claimed
EP-3130586-A1 PROCESS FOR TREATING HOMOSERINE-BASED COMPOUND Cj Cheiljedang Corporation (KR) 2017-02-15 EP claimed
US-20170037019-A1 PROCESS FOR TREATING HOMOSERINE-BASED COMPOUND CJ CHEILJEDANG CORPORATION (KR) 2017-02-09 US claimed
CN-104356099-B Homoserine lactone compounds, its preparation method and application thereof ZHENGZHOU UNIVERSITY (CN) 2016-05-11 CN claimed
CN-104356099-A Homoserine lactone compounds as well as preparation methods and application thereof UNIV ZHENGZHOU 2015-02-18 CN claimed